Search results for: cost cap
Op-Ed: This Is Why CT Can’t Lower Healthcare Costs
After years of deliberation, Connecticut’s state plan to cap healthcare costs has finally identified the drivers of those costs in our state. But the Steering Committee, dominated by healthcare industries, still isn’t brave enough hold the overspenders accountable. They want the profitable industries to come up with ideas to lower their own costs (what could…
Read MoreCT Medicaid costs stable but hospital spending needs monitoring
Download the report Sources below Connecticut Medicaid per member costs are stable and growing slower than other states. CT Medicaid per member costs are lower than all but 27 other states, just below the median. But hospital spending increases could erode that progress. Medicaid is not the driver of rising state budgets, growing less than…
Read MoreLegislators hear voices calling for consolidation protections to lower healthcare costs
Download our testimony Yesterday’s public hearing testimony was largely supportive of two bills to prohibit anti-competitive clauses in hospital system contracts with payers. Seventeen testimonies favored the bills, while eight opposed, mainly calling for more transparency and consistency in contracts. Several testimonies (here, here, here, here, and here) favoring the bills came from state residents…
Read MoreInsurance committee to hear bills that mitigate consolidation and lower healthcare costs
Download our testimony One of the main drivers of Connecticut’s rising healthcare costs is consolidation in the healthcare market, making health coverage increasingly unaffordable for consumers, employers, and businesses. The consolidation of hospitals and providers into large health systems in Connecticut has stifled competition, allowing prices to rise unchecked. Large health systems use anti-competitive contract…
Read MorePrimary care spending boost and capitation didn’t work in private plans either
The big idea circulating in some CT health policy circles to control the costs of healthcare is to boost primary care with tons of money and capitate provider payments. Primary care is regular health care for prevention, like check-ups, and common health problems. A new study finds that the idea failed in private insurance, as…
Read MoreLegislators hear diverse voices favoring competition to control healthcare costs
Update 3/22/2022 — SB-416 passed the Insurance and Real Estate Committee unanimously. Twenty-one organizations and state residents testified in favor of SB-416 in Thursday’s Insurance and Real Estate Committee public hearing. Just three testified against. SB-416 would level the playing field in Connecticut’s healthcare market by prohibiting anti-competitive contract clauses used by large health systems…
Read MoreInsurance committee to hear bill to mitigate consolidation and lower healthcare costs
Download our testimony One of the main drivers of Connecticut’s rising healthcare costs is consolidation in the healthcare market, making health coverage increasingly unaffordable for consumers, employers, and businesses. Next Thursday, March 14th, the insurance committee will hold a public hearing on SB-416, An Act Promoting Competition in Contracts Between Health Carriers and Health Care…
Read MoreTestimony supporting Governor’s drug price cap and opposing OHS primary care plan
The Insurance and Real Estate Committee is hearing today the Governor’s healthcare bills. Areas of disagreement include a proposal to limit how much drug prices can rise and the Office of Health Strategy’s (OHS) plans to cap the growth of overall healthcare spending while doubling spending on primary care. Among non-state agencies, fifteen people and…
Read MoreCTNJ op-ed: Class action against Hartford Healthcare changes the landscape
A new lawsuit filed last week alleges that Hartford Healthcare is manipulating the healthcare market to drive out competition and raise prices for their services, despite their lower quality. The class action suit, brought by six brave Connecticut residents, highlights the harm done to all of us. Ultimately, consumers pay all the bills through our…
Read MoreLast year unjustified price increases for nine drugs cost US healthcare $1.67 billion, Humira accounted for $1.4 billion
According to this year’s report, last year the US health system spent an extra $1.67 billion on price increases for nine drugs that were not supported by clinical evidence. Humira led this year’s list at $1.4 billion, accounting for 84% of US unjustified drug price increases in 2020. Humira aside, the more modest price increases…
Read More